Related Experiment Video
Updated: May 31, 2025
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review
Manjusha Bhange1, Darshan Telange2
1Department of Pharmaceutics, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (DU), Sawangi Meghe, Wardha, Maharashtra, 442001, India. manjusha.pharmacy@dmiher.edu.in.
Abstract:
Liver cancer is one of the most challenging malignancies, often associated with poor prognosis and limited treatment options. Recent advancements in nanotechnology and artificial intelligence (AI) have opened new frontiers in the fight against this disease. Nanotechnology enables precise, targeted drug delivery, enhancing the efficacy of therapeutics while minimizing off-target effects. Simultaneously, AI contributes to improved diagnostic accuracy, predictive modeling, and the development of personalized treatment strategies. This review explores the convergence of nanotechnology and AI in liver cancer treatment, evaluating current progress, identifying existing research gaps, and discussing future directions. We highlight how AI-powered algorithms can optimize nanocarrier design, facilitate real-time monitoring of treatment efficacy, and enhance clinical decision-making. By integrating AI with nanotechnology, clinicians can achieve more accurate patient stratification and treatment personalization, ultimately improving patient outcomes. This convergence holds significant promise for transforming liver cancer therapy into a more precise, individualized, and efficient process. However, data privacy, regulatory hurdles, and the need for large-scale clinical validation remain. Addressing these issues will be essential to fully realizing the potential of these technologies in oncology.
Insights
This review explores how nanotechnology and artificial intelligence (AI) are revolutionizing liver cancer treatment. Combining these technologies offers precise drug delivery and personalized strategies for better patient outcomes.
Area of Science:
- Oncology
- Biotechnology
- Medical Informatics
Background:
- Liver cancer presents significant therapeutic challenges with limited treatment options and poor prognosis.
- Nanotechnology offers targeted drug delivery, improving treatment efficacy and reducing side effects.
- Artificial intelligence (AI) enhances diagnostics, predictive modeling, and personalized treatment strategies.
Purpose of the Study:
- To review the convergence of nanotechnology and AI in liver cancer treatment.
- To evaluate current progress, identify research gaps, and discuss future directions.
- To highlight the potential of integrated AI and nanotechnology for personalized oncology.
Main Methods:
- Literature review of advancements in nanotechnology and AI for liver cancer.
- Analysis of AI's role in nanocarrier design and treatment monitoring.
- Exploration of AI-driven patient stratification and clinical decision-making.
Main Results:
- AI can optimize nanocarrier development and treatment efficacy monitoring.
- Integration of AI and nanotechnology enables precise patient stratification.
- Personalized treatment strategies are enhanced through this technological convergence.
Conclusions:
- The synergy of AI and nanotechnology promises more precise and individualized liver cancer therapy.
- Challenges include data privacy, regulatory approval, and the need for clinical validation.
- Addressing these hurdles is crucial for realizing the full potential in oncology.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...